Becton Dickinson & Co.

BDX
Passed

Company Overview

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Country
US
Market Cap
$69.81B
Last Fiscal Year
2024
Final Shariah Status
Passed
Compliance Analysis Overview

Shariah Compliance Benchmarks:

  • Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
  • Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
Business Compliance
0.00% passed
5% Threshold
0.0%
Liabilities Compliance
28.81% passed
33% Threshold
28.8%
Final Shariah Status
Passed

This stock meets all Shariah compliance criteria according to AAOIFI standards.

Stock Information
Name Becton Dickinson & Co.
Ticker BDX
Main Business Medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Type Securities
Industry Medical Instruments & Supplies
Country US
Market Cap $69.81 B

Shariah Analysis Breakdown

Business compliance Breakdown
Revenue Segment Value ($M) Non-Compliant ($M) Reason
Medical $10,070.0 $0.0 -
Life sciences $5,190.0 $0.0 -
Interventional $4,980.0 $0.0 -
Other $-67.0 $0.0 -
Total $20,173.0 $0.0 0.00% (passed)
Liabilities Compliance Breakdown
Liability Item Value ($M) % of Market Cap
current debt and capital lease obligation $2,170,000,000.0 3.11%
long term debt and capital lease obligation $17,940,000,000.0 25.70%
Total Interest-Bearing Debt $20,110,000,000.0 28.81%
Market Capitalization $69,806,050,400.0 100.00%
Compliance Status Threshold: 33% passed